These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 21403397)

  • 21. Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection.
    Elahi S; Niki T; Hirashima M; Horton H
    Blood; 2012 May; 119(18):4192-204. PubMed ID: 22438246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How do HIV elite controllers do what they do?
    Saag M; Deeks SG
    Clin Infect Dis; 2010 Jul; 51(2):239-41. PubMed ID: 20550453
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.
    Van Gulck E; Bracke L; Heyndrickx L; Coppens S; Atkinson D; Merlin C; Pasternak A; Florence E; Vanham G
    PLoS One; 2012; 7(5):e37792. PubMed ID: 22666392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
    Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies.
    Woldemeskel BA; Kwaa AK; Blankson JN
    EBioMedicine; 2020 Dec; 62():103118. PubMed ID: 33181459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
    Pernas M; Tarancón-Diez L; Rodríguez-Gallego E; Gómez J; Prado JG; Casado C; Dominguez-Molina B; Olivares I; Coiras M; León A; Rodriguez C; Benito JM; Rallón N; Plana M; Martinez-Madrid O; Dapena M; Iribarren JA; Del Romero J; García F; Alcamí J; Muñoz-Fernández M; Vidal F; Leal M; Lopez-Galindez C; Ruiz-Mateos E
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29212942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.
    Buckheit RW; Allen TG; Alme A; Salgado M; O'Connell KA; Huculak S; Falade-Nwulia O; Williams TM; Gallant JE; Siliciano RF; Blankson JN
    Nat Commun; 2012 Mar; 3():716. PubMed ID: 22395607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication
    Jacobs ES; Keating SM; Abdel-Mohsen M; Gibb SL; Heitman JW; Inglis HC; Martin JN; Zhang J; Kaidarova Z; Deng X; Wu S; Anastos K; Crystal H; Villacres MC; Young M; Greenblatt RM; Landay AL; Gange SJ; Deeks SG; Golub ET; Pillai SK; Norris PJ
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primitive hematopoietic cells resist HIV-1 infection via p21.
    Zhang J; Scadden DT; Crumpacker CS
    J Clin Invest; 2007 Feb; 117(2):473-81. PubMed ID: 17273559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals.
    Rotger M; Dang KK; Fellay J; Heinzen EL; Feng S; Descombes P; Shianna KV; Ge D; Günthard HF; Goldstein DB; Telenti A; ;
    PLoS Pathog; 2010 Feb; 6(2):e1000781. PubMed ID: 20195503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
    Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
    J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of plasmacytoid dendritic cell and CD4+ T cell in HIV elite controllers.
    Herbeuval JP; Smith N; Thèze J
    Clin Dev Immunol; 2012; 2012():869505. PubMed ID: 23243424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired replication capacity of acute/early viruses in persons who become HIV controllers.
    Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD
    J Virol; 2010 Aug; 84(15):7581-91. PubMed ID: 20504921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control.
    García M; López-Fernández L; Mínguez P; Morón-López S; Restrepo C; Navarrete-Muñoz MA; López-Bernaldo JC; Benguría A; García MI; Cabello A; Fernández-Guerrero M; De la Hera FJ; Estrada V; Barros C; Martínez-Picado J; Górgolas M; Benito JM; Rallón N
    J Mol Med (Berl); 2020 Aug; 98(8):1093-1105. PubMed ID: 32556382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T Cell Homeostasis Disturbances in a Cohort of Long-Term Elite Controllers of HIV Infection.
    Benito JM; Jiménez-Carretero D; Restrepo C; Ligos JM; Valentín-Quiroga J; Mahillo I; Cabello A; López-Collazo E; Sánchez-Cabo F; Górgolas M; Estrada V; Rallón N;
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells.
    Buckheit RW; Siliciano RF; Blankson JN
    Retrovirology; 2013 Jul; 10():68. PubMed ID: 23816179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.
    Pereyra F; Addo MM; Kaufmann DE; Liu Y; Miura T; Rathod A; Baker B; Trocha A; Rosenberg R; Mackey E; Ueda P; Lu Z; Cohen D; Wrin T; Petropoulos CJ; Rosenberg ES; Walker BD
    J Infect Dis; 2008 Feb; 197(4):563-71. PubMed ID: 18275276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elite control of HIV: is this the right model for a functional cure?
    Cockerham LR; Hatano H
    Trends Microbiol; 2015 Feb; 23(2):71-5. PubMed ID: 25487109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.
    Choudhary SK; Archin NM; Margolis DM
    J Infect Dis; 2008 Apr; 197(8):1162-70. PubMed ID: 18419522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.